Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1995 Jan 28;310(6974):224–226. doi: 10.1136/bmj.310.6974.224

Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region.

C B Woodman 1, A G Threlfall 1, C R Boggis 1, P Prior 1
PMCID: PMC2548620  PMID: 7866124

Abstract

OBJECTIVE--To report the detection rate of interval cancers in women screened by the NHS breast screening programme. DESIGN--Detection of interval cancers by computer linkage of records held by the screening centres in the North Western Regional Health Authority with breast cancer registrations at the regional cancer registry. SETTING--North Western Regional Health Authority. SUBJECTS--137,421 women screened between 1 March 1988 and 31 March 1992 who had a negative screening result. RESULTS--297 invasive interval cancers were detected. The rate of detection of interval cancers expressed as a proportion of the underlying incidence was 31% in the first 12 months after screening, 52% between 12 and 24 months, and 82% between 24 and 36 months. CONCLUSION--The incidence of interval cancers in the third year after breast screening approaches that which would have been expected in the absence of screening and suggests that the three year interval between screens is too long.

Full text

PDF
224

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersson I., Hildell J., Mühlow A., Pettersson H. Number of projections in mammography: influence on detection of breast disease. AJR Am J Roentgenol. 1978 Feb;130(2):349–351. doi: 10.2214/ajr.130.2.349. [DOI] [PubMed] [Google Scholar]
  2. Bassett L. W., Bunnell D. H., Jahanshahi R., Gold R. H., Arndt R. D., Linsman J. Breast cancer detection: one versus two views. Radiology. 1987 Oct;165(1):95–97. doi: 10.1148/radiology.165.1.3628795. [DOI] [PubMed] [Google Scholar]
  3. Chamberlain J., Moss S. M., Kirkpatrick A. E., Michell M., Johns L. National Health Service breast screening programme results for 1991-2. BMJ. 1993 Aug 7;307(6900):353–356. doi: 10.1136/bmj.307.6900.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fletcher S. W., Black W., Harris R., Rimer B. K., Shapiro S. Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst. 1993 Oct 20;85(20):1644–1656. doi: 10.1093/jnci/85.20.1644. [DOI] [PubMed] [Google Scholar]
  5. Frisell J., Eklund G., Hellström L., Somell A. Analysis of interval breast carcinomas in a randomized screening trial in Stockholm. Breast Cancer Res Treat. 1987;9(3):219–225. doi: 10.1007/BF01806383. [DOI] [PubMed] [Google Scholar]
  6. Peeters P. H., Verbeek A. L., Hendriks J. H., Holland R., Mravunac M., Vooijs G. P. The occurrence of interval cancers in the Nijmegen screening programme. Br J Cancer. 1989 Jun;59(6):929–932. doi: 10.1038/bjc.1989.196. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Shapiro S., Venet W., Strax P., Venet L., Roeser R. Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst. 1982 Aug;69(2):349–355. [PubMed] [Google Scholar]
  8. Tabàr L., Fagerberg G., Duffy S. W., Day N. E., Gad A., Gröntoft O. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin North Am. 1992 Jan;30(1):187–210. [PubMed] [Google Scholar]
  9. Tabár L., Faberberg G., Day N. E., Holmberg L. What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast cancer screening trial. Br J Cancer. 1987 May;55(5):547–551. doi: 10.1038/bjc.1987.112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Tabár L., Fagerberg C. J., Gad A., Baldetorp L., Holmberg L. H., Gröntoft O., Ljungquist U., Lundström B., Månson J. C., Eklund G. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet. 1985 Apr 13;1(8433):829–832. doi: 10.1016/s0140-6736(85)92204-4. [DOI] [PubMed] [Google Scholar]
  11. Verbeek A. L., Hendriks J. H., Holland R., Mravunac M., Sturmans F., Day N. E. Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981. Lancet. 1984 Jun 2;1(8388):1222–1224. doi: 10.1016/s0140-6736(84)91703-3. [DOI] [PubMed] [Google Scholar]
  12. van Dijck J. A., Verbeek A. L., Hendriks J. H., Holland R. The current detectability of breast cancer in a mammographic screening program. A review of the previous mammograms of interval and screen-detected cancers. Cancer. 1993 Sep 15;72(6):1933–1938. doi: 10.1002/1097-0142(19930915)72:6<1933::aid-cncr2820720623>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES